Advanced Contrast Enterprises
Revolutionizing Cancer Detection Through Non-Radioactive Multimodal Imaging
A Collaborative Model for Breakthrough Science
Built on a foundation of polymer chemistry and bioimaging expertise, ACE advances its work through a collaboration-driven model, partnering with leading institutions such as the German Cancer Research Center (DKFZ) and Imperial College London.
Powering the Future of Cancer Imaging
ACE is pioneering a new class of contrast agents that merge fluorescence and photoacoustic imaging to deliver deeper, safer, and more precise cancer detection.